Background: The Centers for Medicare and Medicaid Services (CMS) canceled Meaningful Use (MU), replacing it with Advancing Care Information, which preserves many MU elements. Therefore, transitioning from MU stage 1 to MU stage 2 has important implications for the new policy, yet the quality of care provided by physicians transitioning from MU1 to MU2 is unknown. Methods: Retrospective longitudinal evaluation of the quality of care delivered by outpatient physicians at an academic medical center in the transition between MU1 and MU2. Results: Between MU1 and MU2, 4 measures improved: hypertension control (35% vs 40%), influenza immunization (63% vs 68%), tobacco use assessment/counseling (86% vs 96%), and diabetes control (93% vs 96%; P all <.01). One worsened: senior weight screening/follow-up (54% vs 49%; P < .01). Two were unchanged: chlamydia screening and adult weight screening/follow-up. Conclusion: In this single-site study, when clinicians progressed from MU1 to MU2, 4 quality measures improved, 2 were unchanged, and 1 worsened. Analysis of national data should guide policy decisions about the content of MU's successor.
Background: The Centers for Medicare and Medicaid Services (CMS) canceled Meaningful Use (MU), replacing it with Advancing Care Information, which preserves many MU elements. Therefore, transitioning from MU stage 1 to MU stage 2 has important implications for the new policy, yet the quality of care provided by physicians transitioning from MU1 to MU2 is unknown. Methods: Retrospective longitudinal evaluation of the quality of care delivered by outpatient physicians at an academic medical center in the transition between MU1 and MU2. Results: Between MU1 and MU2, 4 measures improved: hypertension control (35% vs 40%), influenza immunization (63% vs 68%), tobacco use assessment/counseling (86% vs 96%), and diabetes control (93% vs 96%; P all <.01). One worsened: senior weight screening/follow-up (54% vs 49%; P < .01). Two were unchanged: chlamydia screening and adult weight screening/follow-up. Conclusion: In this single-site study, when clinicians progressed from MU1 to MU2, 4 quality measures improved, 2 were unchanged, and 1 worsened. Analysis of national data should guide policy decisions about the content of MU's successor.
Authors: Catherine M DesRoches; Eric G Campbell; Christine Vogeli; Jie Zheng; Sowmya R Rao; Alexandra E Shields; Karen Donelan; Sara Rosenbaum; Steffanie J Bristol; Ashish K Jha Journal: Health Aff (Millwood) Date: 2010-04 Impact factor: 6.301
Authors: Julia Adler-Milstein; Catherine M DesRoches; Michael F Furukawa; Chantal Worzala; Dustin Charles; Peter Kralovec; Samantha Stalley; Ashish K Jha Journal: Health Aff (Millwood) Date: 2014-08-07 Impact factor: 6.301
Authors: Lawrence P Casalino; David Gans; Rachel Weber; Meagan Cea; Amber Tuchovsky; Tara F Bishop; Yesenia Miranda; Brittany A Frankel; Kristina B Ziehler; Meghan M Wong; Todd B Evenson Journal: Health Aff (Millwood) Date: 2016-03 Impact factor: 6.301
Authors: Tiffani J Bright; Anthony Wong; Ravi Dhurjati; Erin Bristow; Lori Bastian; Remy R Coeytaux; Gregory Samsa; Vic Hasselblad; John W Williams; Michael D Musty; Liz Wing; Amy S Kendrick; Gillian D Sanders; David Lobach Journal: Ann Intern Med Date: 2012-07-03 Impact factor: 25.391
Authors: Douglas L Weeks; Benjamin J Keeney; Peggy C Evans; Quincy D Moore; Douglas A Conrad Journal: J Gen Intern Med Date: 2015-01 Impact factor: 5.128
Authors: David A Siegel; S Jane Henley; Jennifer M Wike; A Blythe Ryerson; Christopher J Johnson; Judy R Rees; Lori A Pollack Journal: Cancer Date: 2018-03-26 Impact factor: 6.860